Charge pumping technique is investigated for label-free electrical biosensing using a nanogap-embedded biotransistor. Biomolecules immobilized in a nanogap provide additional trap states and charges in the gate dielectric. These two effects give rise to a change of the charge pumping current, which are analyzed by the aid of numerical simulations. To utilize the trap density of gate dielectric as a sensing parameter, proper amplitude of pulse should be applied for charge pumping to exclude the effect of intrinsically retained charges in biomolecules, thereby this proposed technique is available for detection of biomolecules regardless of retained charges.
The label-free detection of biomolecules using a fieldeffect transistor ͑FET͒ has attracted great attention as researchers seek to realize better point-of-care diagnosis systems in which small, low-cost, high-sensitivity detectors with integrated circuits for signal detection, processing, and transmission are utilized. Various device geometries have been reported, including planar FETs, 1 nanowire FETs, 2, 3 and carbon nanotube FETs; 4 however, only a change in the current flow of the semiconducting channel is considered as a sensing parameter to detect a target biomolecule. This restricted sensing scheme has narrowed the scope to the analysis of the fundamental properties of biomolecules. Previously reported biosensing mechanisms involved the diffusion of target molecules in a solution onto semiconducting channel surfaces, interaction with counterpart molecules on the surface, and ensuing modulation of the device characteristics. Consequently, immobilized target molecules induce net electrostatic effects; hence, they influence the conductivity of the channel. Due to not the change in an order of magnitude but in a factor, such sensing scheme suffers from low signal-tonoise ratio. As only a small amount of electrostatic force under a low concentration of target molecules participates in the biosensing procedure, the dimensions of the sensor device must be scaled down to improve sensitivity. 5 This, however, complicates the fabrication of the device.
In our previous work, a unique biomolecular detection method was demonstrated based on charge pumping technique with a nanogap-embedded biotransistor ͑simply biotransistor͒. 6 In the proposed technique, the trap density of the gate dielectric is introduced as a sensing parameter in place of changes of the current flow in the channel. Such trap states initially occur at the interface between the channel and the gate dielectric and/or inside the gate dielectric. Therefore, if additional trap states are provided by biomolecules immobilized inside a nanogap carved by the partial etching of the gate dielectric, variation of the trap density can occur in a measurable quantity by charge pumping in a highly sensitive and stable manner. However, although charge pumping current can be modulated by other effects such as intrinsically retained charges of biomolecules or the changes of electric field arising from the change of dielectric constant in the nanogap region, we simply assumed at that time that other effects can be neglected and biomolecules only have a role of providing additional trap states. Therefore, this study focuses on a method to distinguish the effects by intrinsically retained charges and extrinsically trapped charges in biomolecules by use of a nanogap embedded biotransistor and the well-known negatively charged biotin-streptavidin binding.
Figures 1͑a͒ and 1͑b͒ are schematic diagrams of a biotransistor and the experimental setup for charge pumping, respectively. The measurement procedure for charge pumping to analyze the trap density of the gate dielectric, the detailed fabrication process, and the procedure of the bioexperiment are published elsewhere. 6 In brief, for charge pumping, the source and drain of the biotransistor were grounded. When a pulse was applied to the gate electrode, the condition of the biotransistor was repeatedly switched between the inversion mode and the accumulation mode. Electrons captured in the traps in the inversion mode then recombined with holes in the accumulation mode. This electron-hole recombination process gave rise to a current flow from the substrate to the channel. This is known as charge pumping current ͑I cp ͒.
7,8 I cp is represented by the equation
where ⌬ s is the change of the surface potential, f is the frequency of the applied pulse, A G is the channel area, and D it is the trap density. Due to the immobilized biomolecules in this nanogap, more trap states were provided to the gate dielectric, thereby giving rise to an increase of I cp according a͒ Author to whom correspondence should be addressed. to Eq. ͑1͒. Hence, targeted biomolecules can be electrically detected by charge pumping technique. Figure 1͑c͒ shows experimental results that compare the measured I cp values before and after the binding of biotinstreptavidin in the nanogap. When the concentration of a biotin/phosphate-buffered saline ͑PBS͒ solution was fixed at 10 mM, the modulation of I cp depends on the streptavidin/ PBS solution concentration, which ranged from 20 pM to 2 nM in this case. To confirm that the measured electrical signals indeed originated from the biomolecules in the nanogap, two control experiments were performed. First, it was confirmed that the biomolecules immobilized on the entire surface of the device ͑except inside the nanogap͒ could modulate I cp . To verify this, the same bioexperiment procedure was carried out using a biotransistor without a nanogap as a control. As shown in Fig. 1͑c͒ , for the biotransistor without the nanogap, there was no modulation of I cp . This is an inherent result in that charge pumping is an extraction technique for the trap states of the gate dielectric. Consequently, biomolecules immobilized onto another device surface ͑e.g., biomolecules immobilized on the surface of the gate, source, or drain͒ cannot affect the generation of I cp . Second, saturated streptavidin was used as a false-positive test. Due to the nonspecificity between biotin and saturated streptavidin, I cp remained unchanged. Thus, it is concluded that the modulation of I cp shows high specificity for detecting the biotinstreptavidin binding which was immobilized only in the nanogap. Particularly, it should be noted that statistical fluctuation of the measured data was low. This is in contrast with the severe fluctuation that occurs with the detection of the current change of the channel as a sensing parameter.
9,10
Although it is clearly shown in Fig. 1͑c͒ that only the specific binding of biotin-streptavidin occurring in the nanogap can modulate I cp , the aforementioned assertion that immobilized biomolecules provide extra trap states should be investigated carefully. From Eq. ͑1͒, I cp not only depends on the trap density ͑D it ͒ but also on the change of the surface potential ͑⌬ s ͒. It is known that a streptavidin molecule has a negative net charge. [11] [12] [13] Hence, the modulation of I cp may be responsible for the change of surface potential due to the negatively charged biomolecules. Both effects, from electrically charged biomolecules and additional trap states provided by biomolecules, should be clarified to understand the modulation of I cp .
For a comprehensive study, a numerical device simulation was carried out. 14 Figure 2͑a͒ shows the simulated device structure whose dimension is equivalent to the biotransistor. Simulations were carried out in two cases as follows: ͑1͒ with assigned negative charges; and ͑2͒ with assigned extra traps in the nanogap region. Figures 2͑b͒ and 2͑c͒ show the measured and simulated drain current-gate voltage ͑I D -V G ͒ characteristics of the biotransistor before and after the bioexperiment. The simulated I D -V G curves with the nanogap region filled with negative charges are well fitted to the measured I D -V G curve, as shown in Fig. 2͑b͒ . Likewise, the simulated I D -V G curves with the assigned extra traps in the nanogap region are well matched with the measured I D -V G curve, as shown in Fig. 2͑c͒ . Therefore, from these simulation results, it can be concluded that the two effects from the electrically charged biomolecules and the additional trap states provided by the biomolecules cannot 
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biotransistor cannot clearly discern the dominant factor that modulates I cp . In contrast, charge pumping technique itself can provide a solution to the aforementioned issue. In the application of the pulse waveform for charge pumping, the pulse base level ͑=minimum peak level of the pulse͒ is fixed to Ϫ2 V, as shown in Fig. 3͑a͒ . When negatively charged biomolecules are located in the nanogap, the threshold voltage ͑V T ͒ of the FET is not uniform along the channel but instead increases locally. It should be noted that I cp can be generated as stated above when the biotransistor is switched between the inversion mode and the accumulation mode. Accordingly, if the maximum peak level of the pulse for charge pumping is lower than the locally increased value of V T , the channel under the nanogap cannot be switched to the inversion mode ͓depicted in Fig. 3͑a͒ as a green pulse͔. Therefore, I cp cannot be generated from traps located near the nanogap. This causes the total value of I cp to decrease. However, if the maximum peak level of the pulse is higher than the locally increased V T , the channel under the nanogap can also be switched to the inversion mode ͓depicted in Fig. 3͑a͒ as a purple pulse͔. Consequently, although the V T value of the device is affected by electrically charged biomolecules, the total amount of the generated I cp is uninfluenced if the amplitude of the pulse for charge pumping ͑V ampl ͒ is sufficient to exceed the locally increased V T . The change of the surface potential ͑⌬ s ͒ does not varied regardless of the gate bias ͑V ampl ͒ if the FET can be switched from its accumulation mode to inversion mode; 15 therefore, the single effect of the electrically charged biomolecules can be neglected by charge pumping technique using a proper value of V ampl .
The experimental results shown in Fig. 3͑b͒ are consistent with these interpretations. Because all values of V ampl ranging from 2 to 4 V can sufficiently switch the device into inversion mode, I cp is maintained with a fresh biotransistor. Both terms of Eq. ͑1͒, D it and ⌬ s , are not affected by differentiated values of V ampl . In contrast, the measured values of I cp are not equal to each other due to the differentiated values of V ampl after the bioexperiment. This can be clearly understood by considering that the channel under the nanogap cannot be switched to the inversion mode due to the locally increased V T caused by the charged biomolecules. This leads to the decrease in the total value of I cp when V ampl is 2 V. When a higher V ampl is applied ͑i.e., V ampl = 3 or 3.5 V͒, the influence from the charged biomolecules is reduced. Lastly, when V ampl ͑=4 V͒ is sufficient to exceed the locally increased V T , the one effect of the electrically charged biomolecules can be neglected. Therefore, the source of I cp modulation can be restricted to the other effect, in which additional trap states stem from the biomolecules in the nanogap. These results are in a good agreement with the numerical device simulation data shown in Fig. 3͑b͒ . When negative charges and extra traps are simultaneously assigned in the nanogap region of the simulated structure, tendencies with regard to V ampl are consistent with the measured data. In contrast, when only extra trap states are assigned in the nanogap region, I cp is not modulated properly in the presence of differentiated values of V ampl . This supports the aforementioned explanations in which the sum of the generated I cp is affected by the electrically charged biomolecules.
In summary, although the intrinsically retained charge as well as traps inside biomolecules could modulate I cp , these two effects were distinguishable by charge pumping technique, in which this proposed technique is available for detection of biomolecules regardless of retained charges. 
